HELSINKI, Finland — Finnish bioinformatics software company Euformatics, which develops and sells world-leading NGS interpretation and quality control tools, has signed a distribution agreement with Vietnamese Illumina distributor Biomedic. The agreement builds on Euformatics’ recent announcement of its partnership with Indonesian reseller PT Pandu Biosains and paves the way for a growing user base of its […]
Company launches first-of-its-kind platform for performing no-code CRISPR workflows via any web browser SAN FRANCISCO — Latch Bio, a company building data infrastructure for the biocomputing revolution, today announced the closing of a $5 million seed funding round led by Lux Capital with participation from General Catalyst, Haystack, Fifty Years, and Asimov co-founder and CEO, […]
ONCODNA’S ONCOKDM® CLINICAL INTERPRETATION PLATFORM TO BE OPTIMIZED FOR THE USE WITH SOPHIA DDM™ TO MATCH TUMOR GENOMIC PROFILES WITH TARGETED THERAPIES OncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases, and SOPHiA GENETICS S.A., a healthcare technology company dedicated to establishing the practice […]
Foundational partnership enables access to novel datasets and innovation workflows through Eagle Genomics’ AI-augmented knowledge discovery platform Cambridge and Norwich – Today, Eagle Genomics, a pioneer in applying network science to biology, and leaders in bioscience research the Earlham Institute, are delighted to announce their new partnership focused on providing critical tools required to analyse, explore and […]
Less than 70 years separate us from one of the greatest discoveries of all time: the double helix structure of DNA. We now know that DNA is a sort of a twisted ladder composed of four types of compounds, called bases. These four bases are usually identified by an uppercase letter: adenine (A), guanine (G), […]
AUSTIN, Texas — L7 Informatics, a leader in enterprise-scale digital transformation and automation of scientific processes in the life sciences, announced that it will begin collaborating with ATCC to help enhance the digitalization of its manufacturing and laboratory operations. ATCC, a premier global biological materials and information resource and standards organization, will work with L7|ESP to […]
Award recognizes the role of Congenica’s artificial intelligence initiative in using data to help rare disease patients get the right care faster and more accurately Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce that it is one of […]
Genomenon to Make Essential Genomic Data for Rare Diseases Available to Genetic Testing Labs Worldwide Genomenon, Inc.®, an AI-driven genomics company, today announced a collaboration with Alexion, AstraZeneca Rare Disease that will make critical information needed for the diagnosis and treatment for a set of rare diseases more readily accessible. The goal of this collaboration is to […]
MINNEAPOLIS — Flywheel, the leading biomedical research data management platform, today announces a $22 million Series C funding round, with more financing expected in the coming weeks, as investors show continued confidence in the company’s growth and market impact. The Series C funding supported Flywheel’s recent acquisition of Radiologics. (Graphic: Shutterstock) The funding round is […]
AUSTIN, Texas — L7 Informatics, Inc., a leader in informatics solutions and services for data-intensive scientific applications and personalized medicine, is pleased to announce the release of L7|HUB. L7|HUB is a repository of shared digital content for L7|ESP users. L7|ESP is a composable platform where citizen developers can use building-blocks to create more composite processes. L7|HUB enables users […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
